Tilray
VC Fund
Nanaimo, Canada
Tilray is a cannabis-lifestyle and consumer packaged goods company that offers cannabis, hemp-based foods, and craft beverages. Tilray provides pharmaceutical-grade cannabis products to patients, researchers, pharmacies, and governments, they cultivate and deliver the benefits of medical cannabis safely and reliably. Healthcare practitioners andpatients expect and deserve only the best service and products.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Tilray invests in
Stages Tilray invests in
Countries Tilray invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Brendan Kennedy
|
|||
Rajnish Ohri
|
|||
Investment Focus
Industry
- Cannabis 1 (50%)
- Manufacturing 1 (50%)
- Pharmaceutical 1 (50%)
Stage
- Post-IPO Debt 1 (50%)
- Post-IPO Equity 1 (50%)
Country
- Canada 1 (50%)
- United States 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Brendan Kennedy
Founder and CEO
|
Founder and CEO | Total investments: 0 | Find email | |
Catherine Jacobson
VP, Medical Affairs & Strategy
|
VP, Medical Affairs & Strategy | Total investments: 0 | Find email | |
Christian Groh
Co-Founder
|
Co-Founder | Total investments: 0 | Find email | |
|
Rajnish Ohri
Managing Director of London and Dubai
|
Managing Director of London and Dubai | Total investments: 0 | Find email | |
Shawn Carpenter
Investor
|
Investor | Total investments: 18 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
HEXO
|
HEXO Corp is an consumer packaged goods cannabis company that creates and distributes prize-winning products to serve the global cannabis market. Through its hub and spoke business strategy, HEXO Corp is partnering with Fortune 500 companies, bringing its brand value, cannabinoid isolation technology, licensed infrastructure and regulatoryexpertise to established companies, leveraging their distribution networks and capacity. As one of the largest licensed cannabis companies in Canada, HEXO Corp operates with 1.8 million sq. ft of facilities in Ontario and Quebec and a foothold in Greece to establish a Eurozone processing, production and distribution centre. The Company serves the Canadian adult-use and medical markets. | $155M / Post-IPO Debt / Jul 12, 2022 | |
MedMen
|
MedMen owns and operates licensed cannabis facilities in cultivation, manufacturing, and retail. It supports sensible, clears, and just drug laws that strengthen communities and create economic opportunities. The company offers turnkey services to license holders in the areas of cultivation, extraction, production, and retail operations, bringinginstitutional best practices to this rapidly growing industry.MedMen guides investors through a space that has traditionally lacked institutional operators. Through MedMen Capital, the firm makes strategic investments in key markets across the U.S. and Canada. The company was founded in 2010 and is headquartered in Culver City, California, United States. | $100M / Post-IPO Equity / Aug 17, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Tilray invest in?
Tilray invests primarily in Cannabis, Manufacturing and Pharmaceutical startups, most often at Post-IPO Debt and Post-IPO Equity stage. Most of the 2 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Tilray?
Public channels for Tilray include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Tilray?
The team at Tilray includes Brendan Kennedy (Founder and CEO), Catherine Jacobson (VP, Medical Affairs & Strategy) and Christian Groh (Co-Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
